For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Histogenics Corporation

USPTO Granted Patents = 21

CIPO Patents = 20

EPO Patents = 6

Trademarks = 3

Forward Citations = 391

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Laurence J B Tarrant (19 out of 21 patents)

Robert Lane Smith (13 out of 19 patents)

Akihiko Kusanagi (11 out of 12 patents)

4. Sonya Shortkroff (8 out of 10 patents)

5. Hans P I Claesson (7 out of 9 patents)

6. Shuichi Mizuno (5 out of 12 patents)

7. Toshimasa Tokuno (5 out of 6 patents)

8. Eric J Roos (4 out of 9 patents)

9. Hans Peter Ingemar Claesson (4 out of 4 patents)

10. R Lane Smith (3 out of 9 patents)

11. Mary Beth Schmidt (3 out of 4 patents)

12. Eric Blahut (1 out of 2 patents)

13. Laurence J Berlowitz Tarrant (1 out of 1 patent)

14. Joseph B Khoury (1 out of 11 patents)

15. Laurence J Tarrant (0 patent)

21 patents: Sort by Forward Citations

1. 10900017 - Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof (2021-01-26),

2. 10842610 - Method for use of a double-structured tissue implant for treatment of tissue defects (2020-11-24),

3. 10077420 - Cell and tissue culture container (2018-09-18),

4. 9993326 - Method for use of a double-structured tissue implant for treatment of tissue defects (2018-06-12),

5. 9701940 - Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof (2017-07-11),

6. 9687590 - Double-structured tissue implant and a method for preparation and use thereof (2017-06-27),

7. 9421304 - Method for improvement of differentiation of mesenchymal stem cells using a double-structured tissue implant (2016-08-23),

8. 9393347 - Double-structured tissue implant and a method for preparation and use thereof (2016-07-19),

9. 9393195 - Systems for cartilage repair (2016-07-19),

10. 9149562 - Method for use of a double-structured tissue implant for treatment of tissue defects (2015-10-06),

11. 8921109 - Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof (2014-12-30),

12. 8906686 - Method for preparation of implantable constructs (2014-12-09),

13. 8685107 - Double-structured tissue implant and a method for preparation and use thereof (2014-04-01),

14. 8070827 - Method for use of a double-structured tissue implant for treatment of tissue defects (2011-12-06),

15. 8070810 - Method for repair and reconstruction of ruptured ligaments or tendons and for treatment of ligament and tendon injuries (2011-12-06),

Histogenics Corporation is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal field. Their lead product candidate, NeoCart®, is designed to treat knee cartilage damage using novel tissue engineering and regenerative medicine techniques. Histogenics Corporation is dedicated to improving patients' lives through innovative and effective therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

21 Patents

#55 in Waltham, MA

#905 in Massachusetts

#15,151 in US

#29,031 in the World

Waltham, MA, United States of America

Histogenics Corporation

Forward Citations = 391

27 inventors:

Laurence J B Tarrant (19 out of 21 patents)

Robert Lane Smith (13 out of 19 patents)

Akihiko Kusanagi (11 out of 12 patents)

4. Sonya Shortkroff (8 out of 10 patents)

5. Hans P I Claesson (7 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…